Clinical Trials Browser

Phase 1/2 × Recurrence × idelalisib × Clear all

NCT03257722 2024-02-28

PIL

Phase 1/2 Terminated

4 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence